Robin L. Weaver

1.6k citations
6 papers · 1.3k · 1 hit paper · h-index 6

Impact in

Papers in

Robin L. Weaver

6 papers receiving 1.2k citations

Robin L. Weaver's Hit Papers

Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment 2000 · 575 citations
5750+8+17Years since publication100200300400500

Peers

Robin L. Weaver
Comparison fields: 5 of 73
  • Pathology and Forensic Medicine 775
  • Genetics 403
  • Oncology 485
  • Radiology, Nuclear Medicine and Imaging 391
  • Immunology 251
Replace Conceição Terra Jonas with:
Conceição Terra Jonas France
Juan Pablo Alderuccio United States
Sanne H. Tonino Netherlands
Jocelyn C. Maragulia United States
Laura Clifton‐Hadley United Kingdom
Paul Caveriviere France
Gottfried von Keudell United States
Dipti Talaulikar Australia
Heather Bethea Horne United States
Mars van’t Veer Netherlands
Robin L. Weaver relative to Conceição Terra Jonas France Conceição Terra Jonas's profile →
Citations per field
00.5×2×2.6×
Conceição Terra Jonas · 1×
Citations per year

Countries citing papers authored by Robin L. Weaver

Since Specialization
Citations

This map shows the geographic impact of Robin L. Weaver's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin L. Weaver with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin L. Weaver more than expected).

Fields of papers citing papers by Robin L. Weaver

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin L. Weaver. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin L. Weaver. The network helps show where Robin L. Weaver may publish in the future.

Co-authors

The 21 scholars most cited alongside Robin L. Weaver, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robin L. Weaver Line = papers co-authored together Robin L. Weaver links everyone, so they are left out of the graph.

All Works

6 of 6 papers shown
#Work
1
Rituximab Anti-CD20 Monoclonal Antibody Therapy in Non-Hodgkin’s Lymphoma: Safety and Efficacy of Re-Treatment
Hit paper breakdown →
2000575
2 2004302
3 1999246
4 2001113
5 200624
6
Reducing Behavior Problems in the Elementary School Classroom. IES Practice Guide. NCEE 2008-012.
200820

About Robin L. Weaver

Robin L. Weaver is a scholar working on Pathology and Forensic Medicine, Oncology, Radiology, Nuclear Medicine and Imaging, Genetics and Insect Science, having authored 6 papers that have together received 1.3k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Viral-associated cancers and disorders (1 paper), Chronic Lymphocytic Leukemia Research (1 paper), CAR-T cell therapy research (1 paper) and HER2/EGFR in Cancer Research (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (775 citations), Genetics (403 citations), Oncology (485 citations), Radiology, Nuclear Medicine and Imaging (391 citations) and Immunology (251 citations). Robin L. Weaver has collaborated with scholars based in United States. Frequent co-authors include Antonio J Grillo-López, Myron Stefan Czuczman, Christine A. White, Brian K. Link, Thomas A. Davis, Ronald Levy, Baha Alkuzweny, Peter Joseph McLaughlin, David G. Maloney and Jay A. Rosenberg. Their work appears in journals such as Journal of Clinical Oncology, Annual Review of Medicine and Leukemia & lymphoma.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact